CN Patent
CN102292086B — 药物组合物
Assigned to Sun Pharma Advanced Research Co Ltd · Expires 2013-05-08 · 13y expired
What this patent protects
本发明涉及一种注射用药物组合物,所述的组合物含有治疗有效量的N-(2-吡嗪基)羰基-L-苯基丙氨酰-L-亮氨酸硼酸或它的盐或它的衍生物以及氨基丁三醇,其中所述的组合物是稳定的。
USPTO Abstract
本发明涉及一种注射用药物组合物,所述的组合物含有治疗有效量的N-(2-吡嗪基)羰基-L-苯基丙氨酰-L-亮氨酸硼酸或它的盐或它的衍生物以及氨基丁三醇,其中所述的组合物是稳定的。
Drugs covered by this patent
- Velcade (bortezomib) · Shilpa
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.